Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A DeFronzo

Showing results (11-20 of 355) with videos related to

Pageof 36
Sort By:
The American Journal of Medicine|March 9, 2010
Current issues in the treatment of type 2 diabetes. IntroductionRalph A DeFronzo
Diabetes Care|January 25, 2014
Response to comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?Stanley Schwartz, Ralph A Defronzo
Diabetes Care|July 1, 2010
Reduced time points to calculate the composite indexRalph A DeFronzo, Masafumi Matsuda
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Preface: Cardiorenal Considerations for Type 2 Diabetes-Time to Exit the Dark AgesRalph A DeFronzo, Guest Editor
Expert Review of Endocrinology & Metabolism|February 16, 2019
Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitusCurtis Triplitt, Ralph A DeFronzo
European Heart Journal|June 12, 2015
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetesEle Ferrannini, Ralph A DeFronzo
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 10, 2003
Metabolic and molecular basis of insulin resistanceMandeep Bajaj, Ralph A Defronzo
Carcinogenesis|November 7, 2017
A novel experimental model for human mixed acinar-ductal pancreatic cancerBruno Doiron, Ralph A DeFronzo
Kidney International|June 16, 2026
Role of the Kidney in Glucose Homeostasis: The Basis for Pharmacotherapy and Prevention of Cardio-Renal Complications in DiabetesEugenio Cersosimo, Ralph A DeFronzo
Diabetes/Metabolism Research and Reviews|March 1, 2006
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseasesEugenio Cersosimo, Ralph A DeFronzo
Pageof 36

Showing results (11-20 of 355) with videos related to

Sort By:
Pageof 36
The American Journal of Medicine|March 9, 2010
Current issues in the treatment of type 2 diabetes. IntroductionRalph A DeFronzo
Diabetes Care|January 25, 2014
Response to comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?Stanley Schwartz, Ralph A Defronzo
Diabetes Care|July 1, 2010
Reduced time points to calculate the composite indexRalph A DeFronzo, Masafumi Matsuda
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Preface: Cardiorenal Considerations for Type 2 Diabetes-Time to Exit the Dark AgesRalph A DeFronzo, Guest Editor
Expert Review of Endocrinology & Metabolism|February 16, 2019
Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitusCurtis Triplitt, Ralph A DeFronzo
European Heart Journal|June 12, 2015
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetesEle Ferrannini, Ralph A DeFronzo
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 10, 2003
Metabolic and molecular basis of insulin resistanceMandeep Bajaj, Ralph A Defronzo
Carcinogenesis|November 7, 2017
A novel experimental model for human mixed acinar-ductal pancreatic cancerBruno Doiron, Ralph A DeFronzo
Kidney International|June 16, 2026
Role of the Kidney in Glucose Homeostasis: The Basis for Pharmacotherapy and Prevention of Cardio-Renal Complications in DiabetesEugenio Cersosimo, Ralph A DeFronzo
Diabetes/Metabolism Research and Reviews|March 1, 2006
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseasesEugenio Cersosimo, Ralph A DeFronzo
Pageof 36